HALEOS LABS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Haleos Labs Limited has submitted a compliance certificate from its Registrar & Share Transfer Agent (RTA), Aarthi Consultants Private Limited, for the quarter ended March 31, 2026. The certificate confirms that the RTA has complied with the requirements under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for dematerialization requests received between January 1, 2026 and March 31, 2026. Specifically, the RTA has confirmed completing three actions within 15 days of receipt of dematerialization requests: mutilation and cancellation of physical share certificates, substitution of depository as the registered owner, and ensuring the securities are listed on the relevant stock exchange. The company was formerly known as SMS Lifesciences India Limited and its CIN is L74930TG2006PLC050223.
This is a routine regulatory filing confirming that share dematerialization processes have been handled correctly by the RTA. It carries no direct financial or operational impact on the stock and does not signal any material change in shareholder position.